Latest News

Filters close
Newswise: Check your Health: Sun Safety & Learning your ABCDE’s
Released: 3-Aug-2021 1:15 PM EDT
Check your Health: Sun Safety & Learning your ABCDE’s
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey expert shares how to check for skin cancer.

Newswise: $10M Appropriation from the State of New Jersey for Pediatric Cancer will Help Advance Research and Treatment
Released: 27-Jul-2021 8:05 AM EDT
$10M Appropriation from the State of New Jersey for Pediatric Cancer will Help Advance Research and Treatment
Rutgers Cancer Institute of New Jersey

Governor Phil Murphy recently signed the fiscal year 2022 state budget, which included a $10 million appropriation to support pediatric cancer research. This legislation, which was sponsored by Senate President Stephen M. Sweeney and Senator Anthony M. Bucco, will support the establishment of the Pediatric Cancer Center at Rutgers Cancer Institute of New Jersey, which in partnership with RWJBarnabas Health, is a leader in pediatric cancer research and care.

Newswise: Rutgers Cancer Institute of New Jersey Clinical Leader Recognized as Fellow of the American Society of Radiation Oncology
Released: 26-Jul-2021 8:05 AM EDT
Rutgers Cancer Institute of New Jersey Clinical Leader Recognized as Fellow of the American Society of Radiation Oncology
Rutgers Cancer Institute of New Jersey

Dr. Salma Jabbour has been named a Fellow of the American Society of Radiation Oncology (FASTRO). This distinction honors individuals who have made significant contributions to the society and to the field of radiation oncology through research, education, patient care and service to the field.

Newswise: Protecting your Heart Before, During and After Cancer Treatment
Released: 21-Jul-2021 8:05 AM EDT
Protecting your Heart Before, During and After Cancer Treatment
Rutgers Cancer Institute of New Jersey

Therapies such as chemotherapy, radiotherapy, immunotherapy and other novel targeted treatments that are used to combat many cancers have the potential to contribute to cardiac toxicity. Rutgers Cancer Institute expert sheds light on the field of Cardo-Oncology, which focuses on the prevention and treatment of cardiac-related issues in cancer patients.

Newswise: Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Leader Recognized as NJBIZ 2021 Healthcare Hero
Released: 13-Jul-2021 5:00 PM EDT
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health Leader Recognized as NJBIZ 2021 Healthcare Hero
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences, has been named by the business journal NJBIZ as a 2021 Healthcare Hero in the healthcare professional category.

Newswise: Frequently Asked Questions on Staying Safe in the Sun
Released: 13-Jul-2021 8:05 AM EDT
Frequently Asked Questions on Staying Safe in the Sun
Rutgers Cancer Institute of New Jersey

Ultraviolet rays from the sun can be harmful and damaging to our skin. While skin cancer can be detrimental, it is also highly preventable. Skin cancer expert from Rutgers Cancer Institute answers common questions to protect yourself from the sun.

Newswise:Video Embedded phage-display-based-gene-delivery-a-viable-platform-technology-for-covid-19-vaccine-design-and-development
VIDEO
Released: 7-Jul-2021 2:45 PM EDT
Phage Display-Based Gene Delivery: A Viable Platform Technology for COVID-19 Vaccine Design and Development
Rutgers Cancer Institute of New Jersey

Researchers at Rutgers Cancer Institute of New Jersey, Rutgers New Jersey Medical School (NJMS) and the Center for Theoretical Biological Physics (CTBP) at Rice University in Houston, Texas, have demonstrated that a technology with favorable biological attributes known as phage display could be a viable platform for the development of new vaccines to protect against COVID-19.

Newswise: RWJBarnabas Health and Rutgers Cancer Institute of New Jersey Break Ground on Jack & Sheryl Morris Cancer Center
Released: 24-Jun-2021 3:10 PM EDT
RWJBarnabas Health and Rutgers Cancer Institute of New Jersey Break Ground on Jack & Sheryl Morris Cancer Center
Rutgers Cancer Institute of New Jersey

RWJBarnabas Health and Rutgers Cancer Institute of New Jersey, the state’s only National Cancer Institute-designated Comprehensive Cancer Center, in partnership with the New Brunswick Development Corporation (DEVCO), broke ground on the state’s first freestanding cancer hospital.

Newswise: Rutgers Cancer Institute researchers shortlisted for Cancer Grand Challenges funding
Released: 22-Jun-2021 12:05 PM EDT
Rutgers Cancer Institute researchers shortlisted for Cancer Grand Challenges funding
Rutgers Cancer Institute of New Jersey

A diverse, global team of scientists led by a Rutgers Cancer Institute of New Jersey leader has been selected for the final stages of Cancer Grand Challenges – with a chance of securing a share of $111 million in funding to take on one of cancer’s toughest problems.

Newswise: Pride, Progress and Breaking down Barriers: LGBTQ+ Cancer Concerns
Released: 2-Jun-2021 8:05 AM EDT
Pride, Progress and Breaking down Barriers: LGBTQ+ Cancer Concerns
Rutgers Cancer Institute of New Jersey

A person with cancer who identifies as lesbian, gay, bisexual, transgender or non-binary may have unique concerns about communicating with their cancer care team, navigating the healthcare system and coping with their diagnosis. An expert from Rutgers Cancer Institute calls attention to the healthcare challenges and barriers faced by this community during Pride Month and explains how health care professionals are becoming better allies.

Newswise: Identifying Potential Treatment for Triple Negative Breast Cancer
Released: 1-Jun-2021 8:05 AM EDT
Identifying Potential Treatment for Triple Negative Breast Cancer
Rutgers Cancer Institute of New Jersey

Researchers at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School (NJMS) recently discovered a phage display-based approach to halt tumor growth that could be used to treat triple-negative breast cancer – considered the most aggressive type of breast cancer. The findings were published online in the scientific journal eLife.

Newswise: Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present 
Extensive, Wide-Ranging New Cancer Research Data at the 2021 ASCO Annual Meeting
19-May-2021 1:00 PM EDT
Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Present Extensive, Wide-Ranging New Cancer Research Data at the 2021 ASCO Annual Meeting
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey, a leader in cutting-edge clinical trials and health outcomes analyses and a designated Comprehensive Cancer Center by the National Cancer Institute, together with RWJBarnabas Health, today announced that data from its cancer clinical research program will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held virtually from June 4-8.

Newswise: The Unique Role of the Oncology Nurse: Lifelong Learning, Healing and Helping
Released: 10-May-2021 1:00 PM EDT
The Unique Role of the Oncology Nurse: Lifelong Learning, Healing and Helping
Rutgers Cancer Institute of New Jersey

Oncology nursing is a unique specialty that requires specific knowledge of the biological and psychosocial dimensions of cancer and its effects on individuals and families. Oncology nurse at Rutgers Cancer Institute of New Jersey shares more on the role of oncology nurses and the importance of the oncology nurse certification.

Newswise: Understanding Brain Tumors
Released: 6-May-2021 11:50 AM EDT
Understanding Brain Tumors
Rutgers Cancer Institute of New Jersey

To better understand brain cancer, neuro-oncologist Michael E. Salacz, MD, director of the Neuro-Oncology Program at Rutgers Cancer Institute of New Jersey and associate professor of medicine at Rutgers Robert Wood Johnson Medical School, shares some basic information on types of brain tumors, risk factors and treatment options.

Newswise: The Greatest Gift for Mom: Health and Wellness
Released: 4-May-2021 9:05 AM EDT
The Greatest Gift for Mom: Health and Wellness
Rutgers Cancer Institute of New Jersey

Now more than ever, we are reminded that health and wellness should always be a top priority. National Women’s Health Month and Mother’s Day, both celebrated in May, are important reminders that women can take control of their health by making feasible lifestyle choices and focusing on preventive care to lower the risk of certain cancers.

Newswise: What is Bladder Cancer?
Released: 3-May-2021 10:25 AM EDT
What is Bladder Cancer?
Rutgers Cancer Institute of New Jersey

The bladder, a part of the urinary system, is a hollow organ in the pelvis with the primary function of storing and then eliminating urine that drains into it from the kidney. Cancer of the bladder develops when abnormal cells in the bladder start to grow out of control. Rutgers Cancer Institute expert explains what you need to know.

Newswise:Video Embedded tanning-beds-and-skin-cancer-heeding-the-call-to-action
VIDEO
Released: 28-Apr-2021 12:50 PM EDT
Tanning Beds and Skin Cancer: Heeding the Call to Action
Rutgers Cancer Institute of New Jersey

Public health officials and researchers have become increasingly concerned about the health risks posed by indoor tanning. Researchers at Rutgers Cancer Institute of New Jersey recently addressed the importance of increasing efforts to limit indoor tanning among minors in a viewpoint paper published in the April 28 2021 online edition of JAMA Dermatology.

Newswise: Rutgers Cancer Institute of New Jersey Leader Elected as a Member to the National Academy of Sciences
Released: 27-Apr-2021 12:25 PM EDT
Rutgers Cancer Institute of New Jersey Leader Elected as a Member to the National Academy of Sciences
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey Deputy Director, Chief Scientific Officer, and Associate Director for Basic Research Eileen White, PhD, has been elected to the National Academy of Sciences (NAS). She is among 120 members elected this year in recognition of their distinguished and continuing achievements in original research.

Newswise: $9 Million Contract from National Cancer Institute Awarded for NJ State Cancer Registry
Released: 27-Apr-2021 8:45 AM EDT
$9 Million Contract from National Cancer Institute Awarded for NJ State Cancer Registry
Rutgers Cancer Institute of New Jersey

The New Jersey State Cancer Registry (NJSCR), under the direction of the State Department of Health in partnership with Rutgers Cancer Institute of New Jersey, has been awarded a seven-year, $9,085,109 contract (75N91021D00009) from the National Cancer Institute (NCI) to support core infrastructure and research activities as part of the Surveillance, Epidemiology, and End Results (SEER) Program, the most authoritative source of information on cancer incidence and survival in the United States. The funding will support ongoing cancer surveillance activities at the NJSCR, as well as support enhancements to New Jersey’s electronic reporting systems such as electronic pathology and medical claims data transmissions.

Newswise: Rutgers Cancer Institute of New Jersey Clinical Leader Recognized as Fellow of the American Society of Clinical Oncology
Released: 22-Apr-2021 5:00 PM EDT
Rutgers Cancer Institute of New Jersey Clinical Leader Recognized as Fellow of the American Society of Clinical Oncology
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey Associate Chief of Urology and Urologic Oncology and Director of the Kidney Cancer Program Eric A. Singer, MD, MA, MS, FACS, has been named a Fellow of the American Society of Clinical Oncology (FASCO). This distinction honors members for their extraordinary volunteer service and dedication to the American Society of Clinical Oncology (ASCO).

Newswise: Exploring a New Therapeutic Strategy for T-cell Acute Lymphoblastic Leukemia
Released: 20-Apr-2021 6:05 AM EDT
Exploring a New Therapeutic Strategy for T-cell Acute Lymphoblastic Leukemia
Rutgers Cancer Institute of New Jersey

Researchers from Rutgers Cancer Institute of New Jersey, recently discovered that a mitochondrial uncoupling drug is toxic against leukemic cells, revealing a potential therapeutic strategy against T-ALL.

Newswise: Rutgers Cancer Institute of New Jersey Awarded $1.3M for Cancer Metabolism and Growth Research Program
Released: 14-Apr-2021 8:05 AM EDT
Rutgers Cancer Institute of New Jersey Awarded $1.3M for Cancer Metabolism and Growth Research Program
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute has received a $1.3 million, five-year grant from the National Cancer Institute to support the Cancer Metabolism and Growth and Tumor Host Interactions Training Program which will provide postdoctoral candidates the highest quality training and research experience.

Newswise: Increase your Awareness of Head and Neck Cancers
Released: 12-Apr-2021 10:05 AM EDT
Increase your Awareness of Head and Neck Cancers
Rutgers Cancer Institute of New Jersey

Accounting for approximately four percent of all cancers nationwide according to the National Cancer Institute, head and neck cancer is the term used to describe a number of different malignant tumors that develop in or around the throat, larynx, nose, sinuses and mouth. Even though these cancers are not as prevalent as others, everyone should be aware of risk factors and symptoms.

Released: 12-Apr-2021 9:00 AM EDT
Seeking Therapeutic Strategies against Non-Small Cell Lung Cancer with Autophagy
Rutgers Cancer Institute of New Jersey

Autophagy is a process where a cell eats itself to maintain cellular metabolism during metabolic stress.

Released: 8-Apr-2021 8:05 AM EDT
Addressing Cancer Disparities: Challenges and Creating Change
Rutgers Cancer Institute of New Jersey

Racial and ethnic minority groups, low income, underinsured, or uninsured individuals as well as those living in rural areas, often face greater obstacles when it comes to preventing, treating and surviving cancer.

Released: 6-Apr-2021 8:55 AM EDT
With Testicular Cancer, Being Proactive is Key
Rutgers Cancer Institute of New Jersey

To highlight testicular cancer awareness month, an expert from Rutgers Cancer Institute of New Jersey addresses the basics of testicular cancer and the importance of self checks and talking to your doctor.

Released: 5-Apr-2021 8:50 AM EDT
Cancer Education Web Resources for Patients, Families and the Community Available
Rutgers Cancer Institute of New Jersey

During National Library Week, Rutgers Cancer Institute's medical librarian shares how cancer patients as well as members of the community who are seeking disease specific information are able to access the information they need beyond physical books.

Released: 29-Mar-2021 10:05 AM EDT
Rutgers Cancer Institute of New Jersey Research Leader Elected as a Fellow to the American Association for Cancer Research Academy
Rutgers Cancer Institute of New Jersey

Deputy director, chief scientific officer, and associate director for Basic Research at Rutgers Cancer Institute of New Jersey has been elected to the 2021 class of Fellows of the American Association for Cancer Research (AACR) Academy, a prestigious accolade offered only to individuals whose work has had a significant and enduring impact on cancer research.

Newswise: Planning for Life after Cancer
Released: 25-Mar-2021 11:55 AM EDT
Planning for Life after Cancer
Rutgers Cancer Institute of New Jersey

Oncology Social Worker from Rutgers Cancer Institute of New Jersey provides insight on the survivorship experience and navigating life after cancer.

Newswise: New Director of Neuro-Oncology Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Released: 24-Mar-2021 12:00 PM EDT
New Director of Neuro-Oncology Named to New Jersey’s Only NCI-designated Comprehensive Cancer Center
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey welcomes Michael E. Salacz as director of its Neuro-Oncology Program.

Newswise: Multiple Myeloma Explained
Released: 23-Mar-2021 8:55 AM EDT
Multiple Myeloma Explained
Rutgers Cancer Institute of New Jersey

Expert from Rutgers Cancer Institute of New Jersey shares information on symptoms, treatment and more to highlight multiple myeloma awareness month.

Newswise: Exploring PD-L1 Expression in Malignant Peritoneal Mesothelioma
Released: 19-Mar-2021 12:35 PM EDT
Exploring PD-L1 Expression in Malignant Peritoneal Mesothelioma
Rutgers Cancer Institute of New Jersey

In a recent study from Rutgers Cancer Institute of New Jersey, researchers tested whether or not mesothelioma cancer cells express high amounts of PD-L1, a protein that is abundantly present on some types of cancer cells. The PD-L1 protein is an inhibitory molecule that binds to the PD-1 receptor on T-cells, which are cells known to have the ability to recognize and destroy cancer cells in the body. Results of the work are being shared as a poster presentation at the Society of Surgical Oncology 2021 International Conference on Surgical Cancer Care virtual meeting.

Newswise: Exploring Racial and Ethnic Disparities in Colorectal Cancer Screening among Patients with Diabetes
Released: 18-Mar-2021 8:45 AM EDT
Exploring Racial and Ethnic Disparities in Colorectal Cancer Screening among Patients with Diabetes
Rutgers Cancer Institute of New Jersey

Researcher at Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School has received $400,000 in awards to help identify and overcome multi-level factors such as patient, health professionals and clinic systems affecting optimal use of colorectal cancer preventative screening options for patients with elevated medical and social risks throughout the United States.

Newswise: Growing Together: New Social Work Manager Joins Comprehensive Team at Rutgers Cancer Institute of New Jersey
Released: 17-Mar-2021 9:45 AM EDT
Growing Together: New Social Work Manager Joins Comprehensive Team at Rutgers Cancer Institute of New Jersey
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey welcomes Joan Hogan, MSW, LCSW, OSW-C, as manager of social work. Learn more about her and her plans for expanding the social work program.

Newswise: Exploring Amino Acids Signaling as Intervention for Diabetes and Pancreatic Cancers
11-Mar-2021 3:55 PM EST
Exploring Amino Acids Signaling as Intervention for Diabetes and Pancreatic Cancers
Rutgers Cancer Institute of New Jersey

Researchers from Rutgers Cancer Institute of New Jersey previously identified a small protein called Rab1A that regulates amino acid signaling. In a recent study, researchers explored the physiological role of Rab1A in mammals using mice though a technique in which one of an organism's genes is made inoperative, known as genetic knockout.

Newswise: Kidney Cancer: 5 Things You Need to Know
Released: 8-Mar-2021 9:45 AM EST
Kidney Cancer: 5 Things You Need to Know
Rutgers Cancer Institute of New Jersey

Nearly 74,000 people will be diagnosed with kidney cancer in the United States this year according to the American Cancer Society.

Newswise: Oncology Social Workers: Helping Heal the Wounds We Can’t See
Released: 4-Mar-2021 10:05 AM EST
Oncology Social Workers: Helping Heal the Wounds We Can’t See
Rutgers Cancer Institute of New Jersey

Social workers in the oncology field play a critical role in cancer care, helping patients, their families and caregivers successfully navigate many of the challenges they face, and this important care has continued through the COVID-19 pandemic.

Newswise: Exploring Mutational Signatures Associated with Exposure to Carcinogenic Microplastic Compounds
Released: 3-Mar-2021 8:55 AM EST
Exploring Mutational Signatures Associated with Exposure to Carcinogenic Microplastic Compounds
Rutgers Cancer Institute of New Jersey

According to the World Health Organization (WHO), plastic products and their chemical derivatives present in the environment present public health concerns, including elevated risk of cancer. Researchers from Rutgers Cancer Institute of New Jersey explored to what extent common components in microplastic pollutants cause DNA damage in human cells.

Newswise: Colorectal Cancer: Common Questions Answered
Released: 2-Mar-2021 10:25 AM EST
Colorectal Cancer: Common Questions Answered
Rutgers Cancer Institute of New Jersey

Knowledge can be your fist line of defense against colorectal cancer. Rutgers Cancer Institute expert addresses what you need to know about colorectal cancer screening, treatment and more during colorectal cancer awareness month.

Released: 1-Mar-2021 1:00 PM EST
Rutgers Cancer Institute of New Jersey Experts Available to Discuss Colorectal Cancer Topics through March
Rutgers Cancer Institute of New Jersey

Various specialists from Rutgers Cancer Institute of New Jersey are available for comment on colorectal cancer topics during the month of March to highlight colorectal cancer awareness month.

Newswise: A New Weapon in the Fight against Cancer: Your Computer
Released: 25-Feb-2021 1:20 PM EST
A New Weapon in the Fight against Cancer: Your Computer
Rutgers Cancer Institute of New Jersey

COVID-related restrictions may have disrupted many things in our lives, but the virtual world of science has no such limitations. Rutgers Cancer Institute of New Jersey’s Community Cancer Action Board and the Office of Community Outreach and Engagement together launched a Citizen Scientist Program, a unique opportunity that enables scientists and members of the public to unite towards a common goal— to make advancements in cancer research.

Newswise: Shedding light on the Forgotten Cancer
Released: 23-Feb-2021 8:40 AM EST
Shedding light on the Forgotten Cancer
Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute expert sheds light on sarcoma for rare disease day.

Newswise: Exploring Genetic and Random Influences upon Tumor Formation and Tumor Types
Released: 22-Feb-2021 7:05 AM EST
Exploring Genetic and Random Influences upon Tumor Formation and Tumor Types
Rutgers Cancer Institute of New Jersey

A recent study from Rutgers Cancer Institute of New Jersey tested this possibility by analyzing tumor formation and p53 mutations in mice from different genetic backgrounds. Observations from this work may further elucidate the diversity of cancers in different Li-Fraumeni patients.

Newswise: Negligible Detection of SARS-CoV2 found in Environmental Surface Testing of Hematology/Oncology Inpatient and Outpatient Settings
17-Feb-2021 3:20 PM EST
Negligible Detection of SARS-CoV2 found in Environmental Surface Testing of Hematology/Oncology Inpatient and Outpatient Settings
Rutgers Cancer Institute of New Jersey

Researchers from Rutgers Cancer Institute of New Jersey evaluated the frequency of SARS-CoV-2, the virus that causes COVID-19, on various environmental surfaces in outpatient and inpatient hematology/oncology settings located within Rutgers Cancer Institute and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. The study, published in Cancer, revealed extremely low detection of SARS-CoV-2 on environmental surfaces across multiple outpatient and inpatient oncology areas, including an active COVID-19 floor.


Showing results

150 of 676

close
0.44151